Literature DB >> 11342494

The cost to global health of drug company profits.

R MacDonald, G Yamey.   

Abstract

Keywords:  Health Care and Public Health

Mesh:

Year:  2001        PMID: 11342494      PMCID: PMC1071375          DOI: 10.1136/ewjm.174.5.302

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  4 in total

1.  US changes trade policy on essential medicines.

Authors:  G Yamey
Journal:  BMJ       Date:  1999-12-11

Review 2.  Tropical medicine.

Authors:  H W Murray; J Pépin; T B Nutman; S L Hoffman; A A Mahmoud
Journal:  BMJ       Date:  2000-02-19

3.  US trade action threatens Brazilian AIDS programme.

Authors:  G Yamey
Journal:  BMJ       Date:  2001-02-17

4.  Access to essential drugs in poor countries: a lost battle?

Authors:  B Pécoul; P Chirac; P Trouiller; J Pinel
Journal:  JAMA       Date:  1999-01-27       Impact factor: 56.272

  4 in total
  3 in total

1.  Africa can solve its own health problems.

Authors:  Daniel J Ncayiyana
Journal:  BMJ       Date:  2002-03-23

2.  The world's most neglected diseases.

Authors:  Gavin Yamey; Els Torreele
Journal:  BMJ       Date:  2002-07-27

3.  On the margins of aid orthodoxy: the Brazil-Mozambique collaboration to produce essential medicines in Africa.

Authors:  Giuliano Russo; Lícia de Oliveira; Alex Shankland; Tânia Sitoe
Journal:  Global Health       Date:  2014-09-25       Impact factor: 4.185

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.